|
Agache, D.G., Dupond, A., 1994. Recent advances in non-invasive assessment of human skin blood blow. Acta. Derm. Venereol. (Suppl.) 185, 47-51 Agner, T., Serup, J., 1990. Individual and instrumental variations in irritant patch-test reactions: Clinical evaluation and quantification by bioengineering methods. Clin. Exp. Dermatol. 15, 29-33 Allec, A., A. Chatelus, N. Wagner, 1997. Skin distribution and pharmaceutical aspects of adapalene gel. J. Am. Acad. Dermatol. 36, S119-125 Anand, P., Bloom, S.R., McGregor, G.P., 1983. Topical capsaicin pretreatment inhibits axon reflex vasodilation caused by somatostatin and vasoactive intestinal peptide in human skin. Brit. J. Pharmacol. 78, 665-669 Anon., 1993. Subdivision F Hazard Evaluation - Humans and domestic animals: proposed new guideline section 85-3. Dermal absorption studies of pesticides. Federal Register 58, 54,350Anon. (1994). ECVAM News & Views. ATLA 22: 7-11. Anon., 1994. Proposal for Two New Guidelines on Percutaneous Absorption. OECD Environmental Health and Safety Division Discussion Document, ref. ENV/EHS/HK/mc/94.103, 18 pp. Paris: OECD. Aspe, E., Guy, R.H., Lee, W.A., Kennedy, J.A., Visor, G.C., Ennis, R.D., 1995. Optimization of in vitro flux through hairless mouse skin of cidoflovir, a potent nucleotide analog. J. Pharm. Sci. 84, 750-754 Barichello, J.M., Morishita, M., Takayama, K., Nagai, T., 1999. Absorption of insulin from Pluronic F-127 gels following subcutaneuous administration in rats. Int. J. Pharm. 180, 189-198 Barry, B.W., 1983. Dermatological formulations. Percutaneous absorption.in drugs and the pharmaceutical sciences, Volume 18 (ed. J. Swarbrick), pp. 234-295. New York: Marcel Dekker. Barry, B.W., 1989. Optimising percutaneous absorption. in percutaneous absorption: Mechanisms-Methodology-Drug Delivery, 2nd Edition (ed. R.L. Bronaugh & H.I. Maibach), pp. 531-554. New York: Marcel Dekker. Benfeldt, E., Serup, J., Menné, T., 1999. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non — invasive quantification of barrier funtion. Brit. J. Dermatol. 140, 739-748 Bernstein, J.E., Swift, R.M., Soltani, K. et al., 1981. Inhibition of axon reflex vasodilatation by topically applied capsaicin. J. Invest. Dermatol. 76, 394-395 Bernstein, J.E., 1987. Capsaicin in the treatment of dermatologic disease. Cutis. 39, 352-353 Berrazueta, J.R., Losada, A., Poveda, J., Ochoteco, A., Riestra, A., Salas, E., Amado, J.A., 1996. Successful treatment of shoulder pain syndrome due to supraspinatus otendinitis with transdermal nitroglycerine, A double blind study. Pain. 66, 63-67 Bjerring, P, Arendt-Nielsen, L., 1990. Inhibition of histamine skin flare reaction following repeated topical application of capsaicin. Allergy. 45, 121-125 Bronaugh, R.L. Stewart, R.F., 1984. Methods for in vitro percutaneous absorption studies. III. Hydrophobic compounds. Journal of Pharmaceutical Science 73: 1255-1259 Bronaugh, R.L. Maibach, H.I., 1985. Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in human and monkey skin. J. of Inv. Dermatol. 84, 180-183 Buck, S.H., Burks, T.F., 1990. The neuropharmacology of capsaicin — review of some recent observations. Pharmacol. Rev. 99, 7-8 Buckely, T.L., Brain, S.D., Williams, T.J., 1990. Ruthenium red selectively inhibits oedema formation and increase blood flow induced by capsaicin in rabbit skin. Br. J. pharmacol. 99, 7-8 Bucsics, A., Lembeck, F., 1987. In vitro release of substance P from spinal cord slices by capsaicin congeners. Eur. J. Pharmacol. 71, 71-77 CCIS, computerized clinical information system. Micromedex Inc. Chen, I.J., Yang, J.M., Yeh, J.L., Wu, B.N., Lo, Y.C., Chen, S.J., 1992. Hypotensive and antinociceptive effects of ether-linked and relatively non-pungent analogues of N-nonanoyl vanillylamide. Eur. J. Med. Chem. 27, 187-192 Cordell, G.A., Araujo, O.E., 1993. Capsaicin: identification, nomenclature, and pharmacotherapy. Ann. Pharmacother. 27, 230-236 de Lange, J., van Eck, P., Elliot, G.R., de Kort, L.A.M. & Wolthuis, O.L., 1992. The isolated blood-perfused pig ear: an inexpensive and animal-saving model for skin penetration studies. J. of Pharmacol. Toxicol. Methods 27: 71-77 Degim, I.T., Uslu, A., Hadgraft, J., Atay, T., Akay, C., Cevheroglu, S., 1999. The effects of Azone and capsaicin on the permeation of naproxen through human skin. Int. J. pharm. 19, 21-25 DiBiase, M.D., Rhodes, C.T., 1996. Formulation and evaluation of epidermal growth factor in pluronic F-127 gel. Drug Dev. Ind. Pharm. 22, 823-831 Doelker, E., 1987. Water-swollen cellulose derivatives in pharmacy. In: N.A. Peppas (Eds.), Hydrogels in medicine and pharmacy. Vol. II: Polymers. CRC press, Boca Raton, FL, 115-160 Fang J.Y., Wu, P.C., Huang, Y.B., Tsai, Y.H., 1995. In vitro permeation study of capsaicin and its synthetic derivatives form ointment bases using various skin types. Int. J. Pharm. 126, 119-128 Fang J.Y., Wu, P.C., Huang, Y.B., Tsai, Y.H., 1996a. In vitro percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from ointment bases: pharmacokinetic analysis in rabbits. Int. J. Pharm. 128, 169-177 Fang, J.Y., Wu, P.C., Huang, Y.B., Tsai, Y.H., 1996b. In vitro percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from ointment bases: skin erythema test and non-invasive surface recovery technique in humans. Int. J. Pharm. 131, 143-151 Fang, J.Y., Tsai, M.J., Huang, Y.B.,Wu, P.C., Tsai, Y.H., 1997. Percutaneous absorption and skin erythema: quantification of capsaicin and its synthetic derivatives from gels incorportated with benzalkonium chloride by using non — invasive bioengienry methods. Drug Dev. Res. 40, 56-57 Fang, J.Y., Kuo, C.T., Huang, Y.B., Wu, P.C., Tsai, Y.H., 1999. Transdermal delivery of sodium nonivamide acetate form volatile vehicles: effects of polymers. Int. J. Pharm. 176, 157-167 Fang, J.Y., Fang, C.L., Hong, C.T., Chen, S.Y., Lin, T.Y., Wei, H.M., 2001. Capsaicin and nonivamide as novel skin permeation enhancers for indomethacin. Eur. J. Pharm. Sci. 12, 195-203 Fisher, H.L, Shah, P.V., Sumler, M.R. & Hall, L.L., 1989. In vivo and in vitro dermal penetration of 2,4,5,2'',4'',5''-hexachlorobiphenyl in young and adult rats. Environ. Res. 50, 120-139 Foreman, J.C., Jordan, C.C., Oehme, P., Renner, H., 1983. Structure-activityrelationships for some substance P related peptides that cause wheal and flare reactions in juman skin. J. Physiol. (Lond.). 335, 449-465 Franz, T.J., 1975. In vitro vs in vivo percutaneous absorption - on the relevance of in vitro data. J. of Inv. Dermatol. 64,190-195Buck, S.H., and Burks, T.F., 1986. The neuropharmacology of capsaicin-review of some rescent observations. Pharmacol. Rev. 38, 179-226 Fusco, B.M., Giacovazzo, M., 1997. Peppers and pain. Drugs. 53, 909-914 Gilbert, J.C., Richardson, J.L., Davies, M.C., Palin, K.J., Hadgraft, J., 1987. The effect of solutes and polymers on the gelation properties of Pluronic F-127 solutions for controlled drug delivdery. J. Control. Release 5, 113-118 Hadgraft, J., 1999. Passive enhancement strategies in tropical and transdermal drug delivery. Int. J. Pharm. 184, 1-6 Hakas, J.F., 1990. Topical capsaicin induces cough in patient receiving ACE inhibitor (letter). Ann Allergy. 65, 322 Hayes, A.G., Orford, A., Reynolds, M., Skingler, A.H., Skingler, M., Smith, C., Tyers, M.B., 1984. The effects of a series of capsaicin analogues on nociception and body temperature in the rats. Life Sci. 34, 154-156 Ho, H.O., Huang, F.C., Sokoloski, T.D., Sheu, M.T., 1994. The influence of cosolvents on the in-vitro percutaneous penetration of diclofenac sodium from a gel system. J. Pharm. Pharmacol. 46, 636-642 Hua, X.Y., Saria, A., Gamse, R., 1985. Multiple tachykinins (neurokinin A. neuropeptide Y and substance P) in capsaicin-sensitive neurons in guinea-pig. Regul Pept. 133, 1-19 Hueber, F., H. Schaefer, J. Wepierre, 1994. Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacol. 7, 237-244 Inagi, T., Muramatsu, T., Nagai, H., Terada, H., 1981. Influence of vehicle composition on the penetration of indomethacin through guinea pig skin. Chem. Pharm. Bull. 29, 1708-1714 Izumi, H., Karita, K., 1988. Investigation of mechanisms of the flare and wheal reactions in human skin by band method. Brain Res. 449, 328-331 Jancso, G., Obal, F., Toth-Kasa, I., Katona, M., Husz, S., 1985. The modulation of cutaneous inflammatory reactions by peptide-containing sensory nerves. Int. J. Tissue React. 7, 449-457 Jones, D.S., Woolfson, A.D., Brown, A.F., 1997. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int. J. Pharm. 151, 223-233 Juhasz, K., Tyirak, E., 1969. Pungent substance in the fruit of capsicum genus. Acta agron. 18, 113-120 Kalia, Y.N., Merino, V., Guy, R.H., 1998. Dermatologic therapy. Transdermal drug delivery. Clinical aspects. Derm. Clinics. 16, 289-299 Kalia, Y.N., Alterti, I., Sekkat, N., Curdy, C., Naik, A., Guy, R.H. 2001. Normalization of stratum corneum barrier function and transepidermal water loss in vivo. Pharm. Res. 17, 1148-1150 Kim, S.W., Bae, Y.H., Okano, T., 1992. Hydrogels: Swelling, drug loading, and release, Pharm. Res. 9, 283-290 Lee, C.K., Kitagawa, K., Uchida, T., Kim, N.S., Goto, S., 1995. Transdermal delivery of theophylline using an ethanol/Panasate 800-ethylcellulose gel preparation. Biol. Pharm. Bull. 18, 176-180 Li. Wan. Po. A., 1990. Non prescription drugs 2nd edn. Blackwell oxford Lin, S.Y., Lin, P.C., 1992. Effects of acid type, acetic acid and sodium carboxymethylcellulose concentrations on the formation, micromeritic, dissolution and floating properties of theophylline chitosan microcapsules. Chem. Pharm. Bull. 40, 2491-2497 Lu, J.K., Prudhommeaux, F., Meunier, A., Sedel, L., Guillemin, G., 1999. Effects of chitosan on rat knee cartilages. Biomaterials. 20, 1937-1944 Magnusson, B.M., Koskinen, L.-O. D., 2000. In vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responses. Int. J. pharm. 195, 55-62 Maibach, H.I., 1996. Dermatologic research techniques, CRC Press Inc. McCleane, G.J., McLaughlin, M., 1998. The addition of GTN to capsaicin cream reduces the discomfort associated with application of capsaicin alone. A volunteer study. Pain. 78, 149-151 McCusker, M.T., Chung, K.F., Roberts, N.M., Barnes, P.J., 1989. Effect of topical capsaicin on the cutaneous responses to inflammatory mediators and to antigen in man. J. Allergy Clin. Immunol. 83, 1118-1124 Monsereenusorn, Y., Kongsamut, S., Pezalla, P., 1982. Capsaicin-a literature survey. CRC Crit. Rev. Toxicol. 13, 321-339 Narasimhan, B., Peppas, N.A., 1997. Molecular analysis of drug delivery systms controlled by dissolution of the polymer carrier. J. Pharm. Sci. 86, 297-304 Negulesco, J.A., Noel, S.A., Newman, J.A.I., Nabor, E.C., Bhat, H.B., Witiak, D.T., 1987. Effects of pure capsaicinoids (capsaicin and dihydrocapsaicin) on plasma lipid and lipoprotein concentrations of turkey poults. Athero. 64, 85-90 Nelson, E.K., Dawson, L.E., 1923. The constitution of capsaicin-the pungent principle of capsicum, part 2. J. Am. Chem. Soc. 45, 2179-2181 Nelson, E.K., 1919. Vanillyl-acylamide. J. Am. Chem. Soc. 41, 2121-2130 Nivedita, K., Pandit, Justin, K., 1996. Loss of gelatin ability of pluronic F127 in the presence of some salts. Int. J. Pharm. 145, 129-136 Northan, W.J., Jones, D.J., 1984. Comparison of capsaicin and substance P induced cyclic AMP accumulation in spinal tissue slices. Life Sci. 35, 293-302 Okamoto, Y., Shibazaki, K, Minami, S., Matsuhashi, A., Tanioka, S., Shigamasa, Y., 1995. J. Vet. Med. Sci. 57, 851-854 Okamoto, Y., Tomita, T., Minami, S., Matsuhashi, A., Kumazawa, N. Tanioka, S., Shigamasa, Y., 1995. J. Vet. Med. Sci. 57, 765-767 Pershing, L.K., J. Corlett, C. Jorgensen, 1994. In vivo pharmacokinetics and pharmacodynamics of topical keoconazole and miconazole in human stratum corneum. Antimicrobial agents and chemotherapy. 38, 90-95 Product Information: Zostrix, capsaicin. GenDerm Corporation, Lincolnshire, IL, USA, 1997 Queille-Roussel, C., Poncet, M. & Schaefer, H. 1991. Quantification of skin colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. British J. of Dermatol. 124,264-270. Ralf Baron., 2000. Capsaicin and nocicption: from basic mechanisms to novel drugs. Lancet. 356, 785-786 Ramsey, J.D., Woollen, B.H., Auton, T.R., Batten, P.L. & Leeser, J.E.,1990. Percutaneous absorption of the lipophilic herbicide fluazifop butyl in man. In prediction of percutaneous penetration: methods, measurements, modelling (ed. R.C. Scott, R.H. Guy & J. Hadgraft), pp. 49-57. London: IBC Technical Services. Ramsey, J.D., Woollen, B.H., Auton, T.R. & Scott, R.C., 1994. The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluozifop-butyl) through rat and human skin. Fund. Appl. Toxicol. 23, 230-236 Ranade, V.V. 1991. Drug delivery systems. 6. Trandermal drug delivery. J Clin. Pharmacol. 31, 401-418 Rayner, H.C., Atkins, R.C., Westerman, R.A., 1989. Relief of local stump pain by capsaicin cream. Lancet. 2, 1276-1277 Roberts, R. G. D., Westerman, R. A., Widdop, R. E., Kotzmann, R. R., and Payne, R., 1992. Effects of capsaicin on cutaneous vasodilator responses in humans. Agents Actions. 37, 53-59 Roberts, MS., 1997. Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease. Clin. Exp. Pharmacol. Physiol. 24, 874-879 Robertson, D.R.C., George, C.F., 1990. Treatment of post-herpetic neuralgia in the elderly. Br. Med. Bull. 46,113-123 Rougier, A.,D. Dupusi, C., Lotte, et al., 1983. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J. Invest. Dermatol. 81, 275-278 Rougier, A.,D. Dupusi, C., Lotte, et al., 1986. Regional variation in percutaneous absorption in man: Measurement by the stripping method. Arch. Derm. Res. 278, 465-469 Rougier, A., Rallis, M., Kiren, P., Lotte, C., 1990. In vivo percutaneous absorption: A key role for stratum corneum / vehicle partitioning. Arch. Dermatol. Res. 282, 498-505 Rutherford, T. & Black, J.G., 1969. The use of autoradiography to study the localisation of germicides in skin. Brit. J. Dermatol. 81, Suppl. 4, 75-79 Schaefer, H., Zesch, A. Stuettgen, G., 1982. Editors, Skin Permeability. 541 pp. Berlin: Springer VerlagRougier, A., M. Rallis, P. Kiren, C., Lotte, et al., 1990. In vivo percutaneous absorption: A key role for stratum corneum / vehicle partitioning. Arch. Dermatol. Res. 282, 498-505 Schaefer, H., Redelmeir, T.E., 1996. Skin barrier, principles of pecutsaneous absorption. Eds, Karger Publishers Schmolka, I.R., 1972. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 6, 571-582 Schnetz, E., Diepgen, T.L., Elsner, P., Frosch, P.J., Klotz, A.J., Kresken, J., Kuss, O., Merk, H., Schwanitz, H.J., Wigger-Alberti, W., Fartasch, M., 2000. Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation. Contact Dermatitis. 42, 336-343 Shah, V.P., Maibach, H.I., 1993. Topical drug bioavailability, bioequivalence and penetration, Plenum Press Shah, V.P., Flynn, G.L., Yacobi, A., et al., 1998. Bioequivalence of topical dermatological dosage forms — Methods of evaluation of bioequivalence. Pharm. Res. 15, 167-171 Shin, S.C., Cho, C.W., Choi, H.K., 1999. Permeation of piroxicam fro the poloxamer gels. Drug Dev. Ind. Pharm. 25, 273-278 Simone, D.A., Ochoa, J., 1991. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilation in human. Pain. 47, 285-294 Singh, S., Singh, J., 1993. Transdermal drug delivery by passive diffusion and iontophoresis: A review. Medicinal Res. Rev. 13, 569-621 Sjolund, B.H., Erickson, M.B.E., 1980. Stimulation techniques in the management of pain. In: Kosterlitz H. Terenius L. editors. Pain and society. London: Verlac Chemie. 415 Skelly, J.P., Shah, V.P., Maibach, H.I., Guy, R.H., Wester, R.C., Flynn, G. & Yacobi, A., 1987. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm. Res. 4: 265-267 Stratton, L.P., Dong, A., Manning, M.C., Carpenter, J.F., 1997. Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel. J. Pharm. Sci. 86, 1006-1010 Szallasi, A., Blumberg, P.M., 1993. Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules). Adv. Pharmacol. 24, 123-155 Szallasi, A., Blumberg, P.M ., 1999. Vanilloid (capsaicin) receptors and mechanisms . Pharmacol. revi. 51, 160-202 Tominaga, M., Julius, D., 2000. Capsaicin receptor in the pain pathway. Jpn. J. Phamacol. 83, 20-24 Tsai, Y.H., Huang, Y.B., Fang, J.Y., Wu, P.C., 1994. Percutaneous absorption of capsaicin and its derivatives. Drug Dev. Ind. Pharm. 20, 719-730 Tsai, C.J., Hsu, L.R., Fang, J.Y., Lin, H.H., 1999. Chitosan hydrogel as a base for trnasdermal delivery of berberine and its evaluation in rat skin. Biol. Pharm. Bull. 22, 397-401 Virus, R.M., Gebhart, G.F., 1979. Pharmacologic actions of capsaicin: apparent involvement of substance P and serotonin. Life Sci. 25, 1273-1284 Wallengren, J., Moller, H., 1986. The effect of capsaicin on some experimental inflammations in hyman skin. Acta. Derm. Venereol. (Stockh.). 66, 375-380 Watson, C.P.N., 1989. Postherpetic neuralgia. Neurol Clin North Am. 7, 231-248 Zhang, W.Y., Li. Wan. Po. A., 1994. The effectiveness of topically applied capsaicin, A meta-analysis. Eur. J. Clin. Pharmacol. 46, 517-522
|